United States · FDA National Drug Code directory

Gabapentin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
76420-497_eaa81374-5d2c-60d1-e053-2a95a90af8ea
Product NDC
76420-497
Form
TABLET
Composition / generic term
Gabapentin
Labeler
Asclemed USA, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20160204
Source listing expiry
20261231

Source-listed ingredients

  • GABAPENTIN — 800 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE (76420-497-01) · 76420-497-01
  • 500 TABLET in 1 BOTTLE (76420-497-05) · 76420-497-05
  • 120 TABLET in 1 BOTTLE (76420-497-12) · 76420-497-12
  • 240 TABLET in 1 BOTTLE (76420-497-24) · 76420-497-24
  • 30 TABLET in 1 BOTTLE (76420-497-30) · 76420-497-30
  • 60 TABLET in 1 BOTTLE (76420-497-60) · 76420-497-60
  • 90 TABLET in 1 BOTTLE (76420-497-90) · 76420-497-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →